DJ Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 1.35% to $1.46 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.21% to 21,169.42 and the Dow Jones Industrial Average rising 0.18% to 44,193.12.
The stock's fall snapped a three-day winning streak.
Inovio Pharmaceuticals Inc. closed 83.96% below its 52-week high of $9.10, which the company reached on August 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.09% to $170.59, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 3.31% to $23.93.
Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 06, 2025 17:26 ET (21:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.